Analytical Data
-
基因名
C20orf160
- Application
-
别名
CCM2L; C20orf160Cerebral cavernous malformations 2 Protein-like; CCM2-like
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9NUG4
-
表达区间
1-571aa
-
氨基酸序列
MEYEVKKGKK GFVSPIRRLV FPKAGRRAAC RSSVSRRPLH SMPLYPPDYL IDPQILLCDY LEKEVKFLGH LTWVTSSLNP SSRDELLQLL DTARQLKELP LKTTAEQDSI LSLSARCLLL TWRDNEELIL RIPTHEIAAA SYLQDDALHL LVLKTGLGVD PVPAGVDASP GGAGRDPGPP GGAPEKRRVG TAERRHTICS LDWRMGWGGG AAEARAGGGG GGSLERQRAG ARASGSWERR QTFSGSWERR HGGGGGGGGA GKPGGSWERR QAGSGGGGSW ERRHPGPNPL DPQDPSPDAY CNLVILAVAN RDAAEESCAL ICQVFQIIYG DQSIECVDRA GYHYTSTPER PWLCSRSESC HTDGTYAYDA DFSCCSSFNG SQDTFEACYS GTSTPSFHGS HCSGSDHSSL GLEQLQDYMV TLRSKLGPLE IQQFAMLLRE YRLGLPIQDY CTGLLKLYGD RRKFLLLGMR PFIPDQDIGY FEGFLEGVGI REGGILTDSF GRIKRSMSST SASAVRSYDG AAQRPEAQAF HRLLADITHD IEALAPDDDD DDEDEPRGSR GGSDAAEDNY L
-
分子量
62.1 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C20orf160, a gene located on chromosome 20, has garnered attention in recent years due to its potential role in cellular processes and human health. Preliminary studies have indicated that C20orf160 may be implicated in various biological functions, including cellular signaling, proliferation, and apoptosis. Research on C20orf160 has been driven by its association with several diseases, particularly metabolic disorders and malignancies. The recombinant protein of C20orf160 is of particular interest, as it enables researchers to better understand the protein's structure, function, and interactions within a cellular context. Producing this protein in a recombinant system allows for detailed biochemical characterization, facilitating the investigation of its potential pathways and therapeutic implications. Additionally, understanding the precise role of C20orf160 in disease contexts could lead to the identification of novel biomarkers or therapeutic targets, ultimately advancing personalized medicine approaches. As the field progresses, further studies involving the recombinant C20orf160 protein could provide crucial insights into its biological significance and pave the way for innovative treatments for associated diseases.
